SCHEMBL21314079

SCHEMBL21314079

O=C(c1ccc2[nH]nnc2c1)N1C=C2CN(C(=O)/C=C/c3ccc(-c4ccncc4)cc3)C[C@@H]2C1

nearest known ligand 0.39

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
▸ GPR183 P32249 7/20 0.35
▸ P4HB P07237 1/20 0.33
▸ CCNC P24863 1/20 0.33
▸ CDK8 P49336 1/20 0.33
▸ NAMPT P43490 1/20 0.33
▸ GHSR Q92847 1/20 0.33
▸ ENPP2 Q13822 1/20 0.32
▸ ATXN2 Q99700 1/20 0.32
▸ NPC1 O15118 1/20 0.32
▸ MAPT P10636 1/20 0.32
▸ HPGD P15428 1/20 0.32
▸ RAB9A P51151 1/20 0.32
▸ SMN1; SMN2 Q16637 1/20 0.32
▸ KCNH2 Q12809 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16961653 1.00 GPR183 (0.35) GPR183P4HBCCNCCDK8NAMPT
SCHEMBL16963356 0.91 MKNK1 (0.38) GPR183P4HBNAMPTGHSRHPGD
SCHEMBL21313888 0.91 MKNK1 (0.38) GPR183P4HBNAMPTGHSRHPGD
SCHEMBL21313868 0.89 RAB9A (0.43) GPR183ENPP2ATXN2NPC1MAPT
SCHEMBL16963404 0.89 RAB9A (0.43) GPR183ENPP2ATXN2NPC1MAPT
SCHEMBL21313918 0.88 GPR183 (0.43) GPR183P4HBKCNH2
SCHEMBL16963563 0.88 GPR183 (0.43) GPR183P4HBKCNH2
SCHEMBL16961534 0.88 HTR2B (0.38) GPR183NAMPTGHSRNPC1MAPT
SCHEMBL21313985 0.88 HTR2B (0.38) GPR183NAMPTGHSRNPC1MAPT
SCHEMBL16961652 0.84 CHRNB2 (0.41) GPR183P4HBCCNCCDK8GHSR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2900669-B1 HEXAHYDROPYRROLO[3,4-C]PYRROLE DERIVATIVES AND RELATED COMPOUNDS AS AUTOTAXIN (ATX) INHIBITORS AND AS INHIBITORS OF THE LYSOPHOSPHATIDIC ACID (LPA) PRODUCTION FOR TREATING E.G. RENAL DISEASES HOFFMANN LA ROCHE (CH) 2019-09-04 — — EP disclosed
Send feedback